Latest return on equity
Moleculin Biotech Return on equity
Moleculin Biotech (MBRX) return on equity with its verified observation date.
Direct answer
Moleculin Biotech's return on equity is -1,371.64%.
The verified market snapshot reports -1,371.64%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 27, 2026.
Get free Moleculin Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -1,371.64%
Explore related company data
View Moleculin Biotech's market capitalizationView Moleculin Biotech's p/e ratioView Moleculin Biotech's price-to-book ratioView Moleculin Biotech's 52-week price rangeView Moleculin Biotech's profit marginView Moleculin Biotech's debt-to-equity ratioView all Moleculin Biotech key metricsReturn to Moleculin Biotech profile